Specialty pharmaceutical company

Providing solutions to unmet medical needs.

Shield Therapeutics is a specialty pharmaceutical company focused on the development and commercialisation of late‑stage, hospital‑focused pharmaceuticals which address areas of unmet medical need.

Find out more

Shield Therapeutics hails ‘enormous’ achievement of US regulatory approval

Jul 2019 - 4:28
View all Investors Audio & Video

Our Products

A treatment for iron deficiency anaemia

Our lead product, Ferric Maltol, is a novel oral ferric iron therapy approved by the FDA and will be marketed in the US as Accrufer® and is also approved by the EMA and Swiss Medic and marketed in the European Union as Feraccru® by our commercial partner, Norgine BV.

Find out more